Form 4: InfuSystem Executive Jerod Funke Increases Share Ownership

EVP-Chief HR Officer Jerod Funke acquired 19,753 shares through RSU vestings, bringing his total direct ownership to 29,654 shares.

Summary

• Jerod Funke, EVP-Chief HR Officer, executed multiple transactions involving restricted stock units (RSUs) on May 16 and May 17, 2026.
• A total of 5,183 RSUs vested on May 16, 2026, and were converted to common stock on a one-for-one basis.
• On May 17, 2026, 14,570 performance-based RSUs vested, which were originally granted in May 2024.
• To cover tax liabilities, 8,761 shares were withheld by the company at a price of $8.77 per share, totaling approximately $76,834.
• Following these transactions, the reporting person directly owns 29,654 shares of common stock and holds 10,363 unvested RSUs.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as slightly positive because the vesting of performance-based units suggests the company met internal targets, and the executive has significantly increased his net shareholding.

Positives

• The vesting of 14,570 performance-based RSUs indicates that specific corporate performance milestones were successfully met.
• The executive maintains a significant and growing equity stake in the company, aligning interests with shareholders.
• Direct ownership increased from 18,662 shares to 29,654 shares, a net increase of approximately 59%.

Negatives

• The disposal of 8,761 shares, while for tax purposes, represents a liquidation of equity at a price of $8.77 per share.

Risks

• The executive's compensation is heavily tied to share price performance, which is subject to market volatility.
• Future vestings are contingent on continued employment and potentially further performance hurdles.

Future Outlook

The reporting person holds 10,363 remaining restricted stock units which are scheduled to vest in two equal annual installments beginning on May 16, 2027, and concluding on May 16, 2028.

Management Comments

• The performance-based restricted stock units granted on May 17, 2024, have officially vested as of May 17, 2026.
• Restricted stock units convert into common stock on a one-for-one basis upon vesting.

Industry Context

StockSavvy.ai notes that performance-based equity vesting is a standard mechanism in the healthcare services and medical device industry to ensure executive retention and alignment with long-term strategic goals. InfuSystem's use of these instruments is consistent with mid-cap peers in the medical equipment sector.

Comparison to Industry Standards

• The two-year vesting period for performance units is slightly shorter than the industry average of three years.
• Tax withholding via share cancellation is the standard 'sell-to-cover' or 'net-settlement' method used by most NASDAQ-listed companies.
• The executive's total ownership level is comparable to HR heads at similar-sized medical service firms like Zynex Inc.

Stakeholder Impact

• Shareholders may view the vesting of performance units as a sign of management's ability to hit operational targets.
• The increase in insider ownership generally signals management's confidence in the company's future prospects.

Next Steps

• Vesting of the next installment of 5,181 RSUs on May 16, 2027.
• Final vesting of the remaining RSUs on May 16, 2028.

Key Dates

Recommendation

The filing details routine executive compensation activity. While the vesting of performance units is a positive sign of internal health, it does not represent a new material change in the company's fundamental valuation or strategic direction.

Keywords

InfuSystem Holdings, INFU, Insider Trading, Executive Compensation, Restricted Stock Units, Jerod Funke, Form 4, Medical Equipment